Update in Endocrine Pathology for Surgical Pathologists in the Nordic Region, November 17th-18th 2022
The World Health Organization (WHO) aims to release the 5th edition of the classification of endocrine tumours during the fall-winter of 2022. The course is aimed at highlighting novel concepts from this classification and put focus on practical approaches to diagnostic and prognostic work-up of endocrine tumors in the modern era. Moreover, the molecular background to these lesions is also covered, in order to update the participants regarding potential diagnostic and prognostic markers apart from conventional histology.
"Endocrine pathology is a gaining ground as a hybrid discipline in which histology and molecular analyses are combined to obtain the optimal diagnostic and prognostic work-up for each patient. Therefore, a comprehensive understanding of current histological grading schemes in combination with molecular know-how will be crucial when assessing these lesions in modern pathology practice."
- Christofer Juhlin, course leader
About the course
The course is organized by Dr. Christofer Juhlin, an endocrine pathologist from the Karolinska University Hospital. The course will introduce the course participant to novel concepts and classifications schemes introduced in the latest WHO classificatoin, with focus on thyroid, parathyroid, adrenal and neuroendocrine tumors, and is therefore expected to be of imminent clinical importance for practicing pathologists. The course will also feature lectures by other prominent endocrine pathologists and researchers in the field.
The goal of the course
To provide the course participants the latest definitions of endocrine pathology, in order to keep the diagnostic aspects updated across the Nordic region. Moreover, as molecular pathology is gaining ground as auxiliary markers also in endocrine tumors, this topic will also be comprehensively studied.
Medical doctors and pathologists of any level with special interest in endocrine pathology. Fluency in English is required.
Course set up
The course is based on lectures and case presentations with histological assessments via digital pathology. Summarized literature will be provided to each participant before the start of the course.
Time and place
November 17-18th 2022.
Venue: Karolinska Institutet, Campus Solna, Stockholm.
9 600 SEK (excluding tax).
The fee covers lunch both days and summarized literature.
THURSDAY NOVEMBER 17
10:00-10:15: Introduction (with coffee) - Christofer Juhlin and Anders Höög, KI
10:15-11:00: What's New in Parathyroid Pathology? - Christofer Juhlin, KI
11:00-11:10: Short break
11:10-12:00: Thyroid Pathology: Updates and Novel Concepts - Christofer Juhlin, KI
12:00-12:10: Short break
12:10-13:00: Thyroid Pathology: Updates and Novel Concepts (continued) - Christofer Juhlin, KI
14:00-14:50: Molecular advances in thyroid neoplasia - Johan Paulsson, KI
14:50-15:00: Short break
15:00-15:50: Pituitary neuroendocrine tumors: Advances and Guidelines - Ozgur Mete, Toronto (via link)
15:50-16:00: Short break
16:00-16:45: Neuroendocrine neoplasms: with focus on gastroenteropancreatic tumors - Christofer Juhlin, KI
16:45-16:50: Short break
16:50-17:30: Immunohistochemistry in modern endocrine pathology practice - Anders Höög, KI
17:30 - End of day 1
19:30: Optional course dinner (paid for by participant)
FRIDAY NOVEMBER 18
8:30-9:30: Pheochromocytoma and abdominal paraganglioma: current diagnostic and prognostic algorithms - Christofer Juhlin, KI
9:30-9:45: Short break (with coffee)
9:45-10:45: Benign adrenal cortical disease: aldosterone- and cortisol-producing lesions - Christofer Juhlin, KI
10:45-11:00: Short break
11:00-12:00: Diagnostic algorithms and molecular biology of adrenal cortical carcinoma - Christofer Juhlin, KI
13:00-13:50: Digital slide seminar with equivocal cases (continued) - Christofer Juhlin and Anders Höög, KI
13:50-14:00: Short break
14:00-14:30: Digital slide seminar with equivocal cases (continued) - Christofer Juhlin and Anders Höög, KI
14:30-15:00 Wrap-up and concluding remarks
- Christofer Juhlin and Anders Höög, KI
CHRISTOFER JUHLIN, MD, PH
Deputy Senior Consultant in Endocrine Pathology at the Karolinska University Hospital, Stockholm. Associate Professor, Karolinska Institutet, Stockholm. Christofer is the head of Endocrine Pathology at the Karolinska University Hospital, with experience in diagnosing endocrine tumors and heavily involved in research revolving molecular mechanisms underlying the development of these lesions.
ANDERS HÖÖG, MD, PHD
Senior Consultant in Endocrine Pathology at the Karolinska University Hospital, Stockholm. Associate Professor, Karolinska Institutet, Stockholm. Anders was originally taught endocrine pathology by Professor Lars Grimelius and has 30 years of experience in diagnosing endocrine tumors. He is also involved in research with special focus on immunohistochemistry to facilitate the diagnostic work-up.
OZGUR METE, MD, FRCPC
Consultant in Endocrine Pathology, University Health Network, Toronto. Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto. Ozgur is a world-leading endocrine pathologist, and current president of the Endocrine Pathology Society and Editor-in-Chief of Endocrine Pathology, the Official Journal of Endocrine Pathology Society.
JOHAN PAULSSON, MD, PHD
Intern MD, Karolinska University Hospital, Stockholm. Johan finished his PhD studies in 2021, and his thesis was focused on molecular aberrations of thyroid tumors. His work has led to the implementation of clinical routine TERT promoter mutational screening at Karolinska.
If you are several participants from the same organisation/employer who wish to register for the course, please contact project coordinator Nadja Saltell, email: firstname.lastname@example.org